Neuropathology Patterns and Introduction

Practical Surgical Neuropathology: A Diagnostic Approach

Volumn , Issue , 2010, Pages 1-14

  Perry, Arie ^a   Brat, Daniel J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882489186     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06982-6.00001-8     Document Type: Chapter

References (12)

1. Bailey P., Cushing H. A Classification of Tumors of the Glioma Group on a Histogenetic Basis with a Correlation Study of Prognosis 1926, Lippincott, Philadelphia.
2. Canoll P., Goldman J.E. The interface between glial progenitors and gliomas. Acta Neuropathol. 2008, 116:465-477.
3. Eberhart C.G. In search of the medulloblast: neural stem cells and embryonal brain tumors. Neurosurg Clin North Am. 2007, 18:59-69. viii-ix.
4. Kernohan J.W., Mabon R.F., et al. A simplified classification of the gliomas. Mayo Clin Proc. 1949, 24:71-75.
5. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K. WHO Classification of Tumours of the Central Nervous System 2007, IARC, Lyon.
6. Hasselblatt M., Paulus W. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas. Acta Neuropathol (Berlin) 2003, 106:385-388.
7. Kawano N., Yasui Y., Utsuki S., et al. Light microscopic demonstration of the microlumen of ependymoma: a study of the usefulness of antigen retrieval for epithelial membrane antigen (EMA) immunostaining. Brain Tumor Pathol. 2004, 21:17-21.
8. Park S.Y., Kim B.H., Kim J.H., et al. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007, 131:1561-1567.
9. Takei H., Bhattacharjee M.B., Rivera A., et al. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med. 2007, 131:234-241.
10. Fuller C.E., Perry A. Molecular diagnostics in central nervous system tumors. Adv Anat Pathol. 2005, 12:180-194.
11. Griffin C.A., Burger P., Morsberger L., et al. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol. 2006, 65:988-994.
12. Jenkins R.B., Blair H., Ballman K.V., et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006, 66:9852-9861.